Evidence map›Paper›PMID 40290505›Full record

ArticleFrontiers in public health2025

Do the diagnosis-related group payment reforms have a negative impact?-an empirical study from Western China.

Jia-Yi Wang, Meng-En Chen, Xue-Xuan Wei, Xi-Zhu Lu, Yuan-Rui Zhu, Jing-Yu Yang

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jia-Yi WangSchool of Health Management, Gansu University of Chinese Medicine, Lanzhou, China.
Meng-En ChenSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xue-Xuan WeiSchool of Public Health, Lanzhou University, Lanzhou, China.
Xi-Zhu LuSchool of Public Health, Lanzhou University, Lanzhou, China.
Yuan-Rui ZhuSchool of Health Management, Gansu University of Chinese Medicine, Lanzhou, China.
Jing-Yu YangSchool of Health Management, Gansu University of Chinese Medicine, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The first Diagnosis-Related Group (DRG) Reimbursement pilots in China, which started in 2019, marked an essential step in cost control and service efficiency in Chinese hospitals, but some adverse effects inevitably emerged during the implementation of DRG in TCM (traditional Chinese medicine) hospitals. This study aims to explore the positive and negative effects of DRG payment reform and provide a reference for the reform of medical insurance payments in countries that retain traditional medicine. Methods: Longitudinal data from two hospitals, Qingyang City Hospital of TCM and Tianshui City Hospital of TCM, were retrieved from China's Gansu Health for All Big Data Platform from June 2016 to June 2022, and the policy effects were assessed using the difference-in-differences (DID) method and mediated-effects model. Results: The DRG reform reduced hospitalization costs, diagnostic costs, drug costs, and nursing costs by 6.5, 4.2, 7.9, and 26.2%, respectively, in the treatment group hospitals ( Conclusion: The reform of the DRG payment method has positively impacted the cost control of TCM hospitals, but it has also had some adverse effects. This poses a challenge and prompts a thought about how TCM hospitals can maintain their distinctive advantages by optimizing the design of the DRG system at present.

Indexed as

Diagnosis-Related GroupsHealth Care ReformMedicine, Chinese TraditionalChinaEmpirical ResearchFemaleHealth ExpendituresHospitalizationHumansLongitudinal StudiesMaleMiddle AgedDRGhospitalization timesnegative effectsTCM hospitalstype of medical insurancewesternization

Identifiers

PMID40290505
PMCPMC12021814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.